Olafur A Stefansson

Olafur A Stefansson

UNVERIFIED PROFILE

Are you Olafur A Stefansson?   Register this Author

Register author
Olafur A Stefansson

Olafur A Stefansson

Publications by authors named "Olafur A Stefansson"

Are you Olafur A Stefansson?   Register this Author

26Publications

880Reads

5Profile Views

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

Telomere Length Is Predictive of Breast Cancer Risk in Mutation Carriers.

Cancer Epidemiol Biomarkers Prev 2017 08 24;26(8):1248-1254. Epub 2017 Feb 24.

Cancer Research Laboratory, Biomedical Center, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-16-0946DOI Listing
August 2017

Obesity and menopause modify the epigenomic profile of breast cancer.

Endocr Relat Cancer 2017 07 25;24(7):351-363. Epub 2017 Apr 25.

Cancer Epigenetics and Biology Program (PEBC)Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0565DOI Listing
July 2017

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

A DNA methylation-based definition of biologically distinct breast cancer subtypes.

Mol Oncol 2015 Mar 5;9(3):555-68. Epub 2014 Nov 5.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia 08908, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1016/j.molonc.2014.10.012
Publisher Site
http://dx.doi.org/10.1016/j.molonc.2014.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528700PMC
March 2015

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers.

J Pathol Clin Res 2015 Jan 7;1(1):33-40. Epub 2014 Nov 7.

Cancer Research Laboratory, Biomedical Center, Faculty of Medicine, School of Health Sciences, University of Iceland Reykjavik Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858119PMC
January 2015

A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition.

Cancer Res 2014 Oct 8;74(19):5608-19. Epub 2014 Aug 8.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat; Barcelona, Spain. Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-3659DOI Listing
October 2014

CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancer.

Breast Cancer Res 2014 May 19;16(3):307. Epub 2014 May 19.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de L'Hospitalet 199-203, L'Hospitalet del Llobregat, Barcelona, Catalonia, 08908, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053224PMC
May 2014

Linkage of DNA methylation quantitative trait loci to human cancer risk.

Cell Rep 2014 Apr 3;7(2):331-338. Epub 2014 Apr 3.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, 08036 Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2014.03.016DOI Listing
April 2014

Epigenetic modifications in breast cancer and their role in personalized medicine.

Am J Pathol 2013 Oct 27;183(4):1052-1063. Epub 2013 Jul 27.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, Barcelona, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Spain; Catalonian Institute for Research and Advanced Studies (ICREA), Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2013.04.033DOI Listing
October 2013

Tumour diploidy and survival in breast cancer patients with BRCA2 mutations.

Breast Cancer Res Treat 2013 Jul 16;140(2):375-84. Epub 2013 Jul 16.

Icelandic Cancer Registry, Icelandic Cancer Society, Skogarhlid 8, P.O. Box 5420, 125, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2637-4DOI Listing
July 2013

BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer.

Epigenetics 2012 Nov 15;7(11):1225-9. Epub 2012 Oct 15.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, Barcelona, Catalonia Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/epi.22561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499323PMC
November 2012

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression.

Breast Cancer Res 2011 Sep 29;13(5):R95. Epub 2011 Sep 29.

Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262207PMC
September 2011

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer.

Breast Cancer Res 2006 ;8(4):R38

The Icelandic Cancer Society, Molecular and Cell Biology Research Laboratory, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779478PMC
January 2007